Eton Pharmaceuticals, Inc.
ETON
$58.83
-$0.52-0.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 645.05% | 4.79% | 176.96% | 25.45% | -64.44% |
| Total Depreciation and Amortization | 22.55% | 11.21% | 0.79% | 0.40% | -0.79% |
| Total Amortization of Deferred Charges | 35.59% | -32.57% | -2.23% | 272.92% | -83.67% |
| Total Other Non-Cash Items | 18.47% | -32.94% | 30.03% | -26.99% | 34.31% |
| Change in Net Operating Assets | -436.01% | 114.34% | -267.96% | 67.51% | 5,516.67% |
| Cash from Operations | -2.03% | 164.11% | -196.05% | 51.10% | 280.81% |
| Capital Expenditure | 106.67% | -53.06% | 82.75% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.03% | -30,665.31% | 82.75% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 110.51% | 229.93% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.47% | 229.93% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.38% | 43.81% | -195.21% | 47.53% | 220.41% |